指南与共识创伤与烧伤重症综合管理与镇静镇痛

药师对创伤患者外科ICU预防性依诺肝素监测与剂量调整的建议

Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit.
指南 / 共识 · Pharm Pract (Granada) · 2019-10-31
一句话结论创伤外科ICU患者中,药师提供预防性依诺肝素监测建议的接受率为89.4%,按建议调整剂量后70.4%患者达到目标抗Xa谷浓度0.11-0.20 IU/mL。

该研究为单中心回顾性研究,纳入2017年6月1日至2018年3月1日期间在外科ICU接受至少连续三剂预防性依诺肝素后检测抗Xa谷浓度的42例成人创伤患者。药师在97.6%(41/42)患者中提供至少1条建议,共170条建议,人均4.2条(SD 1.8)。医疗提供者接受89.4%(152/170)的药学建议。按建议调整剂量后有27例复查抗Xa谷浓度,其中19例(70.4%)达到目标范围0.11-0.20 IU/mL。作者认为需进一步研究确定创伤患者静脉血栓栓塞预防的最佳依诺肝素剂量。

要点

  • 药师在97.6%(41/42)创伤外科ICU患者中提供预防性依诺肝素监测建议,共170条,人均4.2条(SD 1.8)。
  • 医疗提供者接受89.4%(152/170)的药学建议,接受率较高。
  • 按药师建议调整剂量后复查抗Xa谷浓度的27例中,19例(70.4%)达到目标0.11-0.20 IU/mL。
  • 药师建议类型包括:获取抗Xa谷浓度90条、根据抗Xa谷浓度调整剂量58条、根据抗Xa谷浓度维持剂量22条。
  • 作者认为需进一步研究确定创伤患者静脉血栓栓塞预防的最佳依诺肝素剂量。

适用人群与场景

  • 成人创伤患者,收入外科ICU,接受至少连续三剂预防性依诺肝素后检测抗Xa谷浓度。
  • 排除:年龄小于18岁;抗Xa水平非谷浓度;抗Xa谷浓度非稳态;非创伤预防性依诺肝素剂量。

诊断标准与关键阈值

  • 目标抗Xa谷浓度(AFXa-TR)为0.11-0.20 IU/mL。

处置流程与药物剂量

  • 药师建议获取抗Xa谷浓度(n=90条建议)。
  • 药师建议根据抗Xa谷浓度调整依诺肝素剂量(n=58条建议)。
  • 药师建议根据抗Xa谷浓度维持依诺肝素剂量(n=22条建议)。

研究设计与关键结果

  • 单中心回顾性研究,最终分析42例创伤外科ICU患者,2017年6月1日至2018年3月1日期间纳入。
  • 药师在97.6%(41/42)患者中提供至少1条建议,共170条建议,人均4.2条(SD 1.8)。
  • 医疗提供者接受89.4%(152/170)的药学建议。
  • 33例按药师建议调整剂量,其中27例至少调整一次剂量后复查抗Xa谷浓度,19/27(70.4%)达到目标范围0.11-0.20 IU/mL。

证据类型、等级与局限

  • 证据类型:单中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 药师参与创伤外科ICU预防性依诺肝素监测可提供监测和剂量调整建议,医疗提供者接受率较高(89.4%),按建议调整后多数复查患者(70.4%)达到目标抗Xa谷浓度。
  • 作者认为需进一步研究确定创伤患者静脉血栓栓塞预防的最佳依诺肝素剂量。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There is limited information describing pharmacist participation in prophylactic enoxaparin monitoring in the surgical intensive care unit (SICU).

OBJECTIVE: Our study sought to: 1) characterize pharmacist recommendations for enoxaparin monitoring in trauma patients admitted to the SICU, 2) describe the frequency that medical providers accept pharmacist recommendations for enoxaparin monitoring in trauma patients admitted to the SICU, and 3) illustrate the frequency that trauma patients admitted to our SICU service achieve anti-factor Xa trough concentrations (AFXa-TRs) of 0.11 - 0.20 IU/mL following pharmacist recommendation to adjust prophylactic enoxaparin dosing.

METHODS: Adult patients who had an AFXa-TR drawn after at least three consecutive prophylactic enoxaparin doses between June 1, 2017 and March 1, 2018 were identified through chart review and included in this study. Patients were excluded based on the following criteria: 1) age less than 18 years, 2) anti-factor Xa (AFXa) level not representative of a trough concentration, 3) AFXa-TR not representative of steady state concentration, and 4) non-trauma based prophylactic enoxaparin dosing. This study was exempt from IRB review.

RESULTS: The final analysis consisted of 42 patients. A pharmacist provided at least one recommendation in 97.6% (41/42) of trauma patients with enoxaparin monitoring during their SICU stay. In total, a pharmacist made 170 recommendations, mean of 4.2 (SD 1.8) recommendations per patient. Recommendations were: 1) obtain an AFXa-TR, n=90; 2) adjust enoxaparin dose based on AFXa-TR, n=58; and 3) maintain enoxaparin dose based on AFXa-TR, n=22. Medical providers accepted 89.4% (152/170) of pharmacist recommendations for enoxaparin monitoring. Dose adjustments were made in 33 patients following pharmacist recommendation; of these, 27 had a repeat AFXa-TR following at least one dose adjustment. Target AFXa-TRs were achieved in 19/27 patients, indicating 70.4% had recommended AFXa concentrations.

CONCLUSIONS: Pharmacists provided recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to the SICU. Medical providers regularly accepted pharmacist recommendations and trauma patients commonly achieved target AFXa-TR following pharmacist recommendation for dose adjustment. Further research is required to identify the optimal enoxaparin dose for VTE prophylaxis in trauma patients.

来源:Pharm Pract (Granada),查看原文。版权归原作者所有。

参考来源

  1. Scrimenti A, Seabury RW, Miller CD, et al. Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit. Pharm Pract (Granada). 2019. PMID: 31897248. doi:10.18549/PharmPract.2019.4.1541

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。